Home Publications AMRC submission to the Department of Health consultation on proposals to transfer functions from the HFEA and the HTA

AMRC submission to the Department of Health consultation on proposals to transfer functions from the HFEA and the HTA

28 September 2012

Key points:

  • Any changes to the current system should be made with a view to streamlining the experience of conducting research, ensuring regulation is proportionate and effective and with public safety central to benefit patients. The eventual aim should be for researchers to experience a one-stop-shop when engaging with regulators.
  • Central to any successful improvements is public confidence. Key characteristics of the regulators which underpin this confidence and must be retained, sufficiently financed and resourced are:
    • Expertise in monitoring scientific progress, advising and making regulatory decisions
    • Conducting deliberative dialogue supporting policy development
    • Transparency of process and a recognised public face
  • Function first, form second. The required functionality can be delivered by several of the structural options proposed.
    • No functions should be moved to organisations that are not fit-for purpose
    • Reorganisation should be focused on improving the operation of these regulators.
    • A review of functions would be valuable to improve delivery of regulation in areas involving human tissue, gene therapies or human stem cells
  • The key issues we have raised are shared across the community and should be taken into account, whichever model is adopted.
Download
Advisory status:
No Status
Document type 
Tags: HFEA, HTA